8-K: Symbotic Reports Strong FY25 Growth, Q4 Revenue Beats

Symbotic Inc. announced robust financial results for fiscal year 2025, with significant revenue growth and positive adjusted EBITDA, while also providing a positive outlook for Q1 fiscal year 2026.

Summary

• Symbotic reported revenue of $618 million for the fourth fiscal quarter of 2025, compared to $565 million in Q4 fiscal year 2024.
• A net loss of $19 million was recorded for Q4 fiscal year 2025, contrasting with net income of $16 million in Q4 fiscal year 2024.
• Adjusted EBITDA for Q4 fiscal year 2025 was $49 million, an increase from $42 million in Q4 fiscal year 2024.
• For the full fiscal year 2025, revenue reached $2,247 million, representing 26% growth year-over-year.
• The full fiscal year 2025 saw a net loss of $91 million, compared to $84.672 million in fiscal year 2024.
• Adjusted EBITDA for the full fiscal year 2025 was $147 million, a significant increase from $61.692 million in fiscal year 2024.
• Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of Q4 fiscal year 2025.
• Medline was added as the first customer in the healthcare vertical.
• The company maintains a total contracted backlog of $22.5 billion as of Q4 fiscal year 2025.
• As of Q4 fiscal year 2025, there are 50 systems in deployment and 48 operational systems across 11 customers.
• Symbotic holds over 650 issued patents and generated positive free cash flow for fiscal year 2025.

Sentiment

Score: 8

Explanation: The company demonstrated strong revenue growth and significant improvements in adjusted EBITDA and free cash flow, indicating robust operational performance and market traction. The expansion into the healthcare vertical and a substantial backlog provide a positive outlook, despite continued GAAP net losses.

Positives

• Achieved strong top-line growth with full fiscal year 2025 revenue increasing 26% year-over-year to $2,247 million.
• Experienced a significant rise in operational systems, reaching 48 operational systems and 50 in deployment.
• Delivered strong gross margin expansion, with adjusted gross profit margin at 22.1% in Q4 FY25, up from 17.9% in Q4 FY24.
• Reported positive adjusted EBITDA of $49 million for Q4 FY25 and $147 million for the full fiscal year 2025, a substantial increase from $61.692 million in FY24.
• Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million, indicating strong liquidity.
• Successfully expanded into a new market vertical by adding Medline as the first customer in healthcare.
• Q4 FY25 revenue exceeded expectations.
• Maintained a substantial contracted backlog of $22.5 billion, providing future revenue visibility.
• Generated positive free cash flow of $787,909 thousand for fiscal year 2025.

Negatives

• Reported a GAAP net loss of $19 million for Q4 FY25, a decline from net income of $16 million in Q4 FY24.
• The full fiscal year 2025 net loss increased to $91 million from $84.672 million in FY24.
• Operating expenses increased, with research and development expenses at $216,013 thousand and selling, general, and administrative expenses at $298,730 thousand for FY25.
• Incurred a loss from equity method investment of $5,885 thousand in Q4 FY25 and $13,716 thousand for FY25.

Risks

• Forward-looking statements are inherently subject to risks, uncertainties, and assumptions.
• The ability to meet the technical requirements of existing or future supply agreements with customers, including with respect to existing backlog.
• Challenges in expanding the target customer base and maintaining the existing customer base.
• Uncertainty in realizing the benefits expected from the GreenBox Systems LLC joint venture, the commercial agreement with GreenBox, the commercial agreement with Nueva Wal Mart de México, S. de R.L. de C.V, and the acquisition of the Advanced Systems and Robotics business from Walmart.
• The ability to realize the company's outlook, including its system gross margin.
• Difficulties in anticipating industry trends and rapid technological changes.
• Challenges in executing the growth strategy and developing, designing, and selling systems that are differentiated from those of competitors.
• Risks associated with acquiring, maintaining, protecting, and enforcing intellectual property.
• The ability to attract, train, and retain effective officers, key employees, or directors.
• Compliance with laws and regulations applicable to the business and staying abreast of modified or new laws and regulations.
• The ability to successfully defend litigation.
• Potential need to issue equity securities in connection with future transactions.
• Challenges in meeting future liquidity requirements and, if applicable, complying with restrictive covenants related to long-term indebtedness.
• The timely and effective remediation of any material weaknesses in internal control over financial reporting.
• Maintaining the listing of Symbotic common stock on Nasdaq.
• The ability to effectively respond to general economic and business conditions.
• Business disruption, including disruption due to dependency on Walmart.
• Increasing competition in the warehouse automation industry.
• Any delays in the design, production, or launch of systems and products.
• The failure to meet customers' requirements under existing or future contracts or customers' expectations as to price or pricing structure.
• Any defects in new products or enhancements to existing products.
• The fluctuation of operating results from period to period due to factors such as the pace of customer adoption of new products and services and any changes in product mix that shift too far into lower gross margin products.
• Any consequences associated with joint ventures and legislative and regulatory actions and reforms.

Future Outlook

For the first quarter of fiscal 2026, Symbotic expects revenue of $610 million to $630 million and adjusted EBITDA of $49 million to $53 million. The start of fiscal year 2026 is unfolding consistent with prior expectations as customers continue their transition to the next generation storage structure.

Management Comments

• "We delivered on our commitments to achieve strong top-line growth, a significant rise in operational systems, and strong margin expansion in fiscal year 2025 as we continue to enhance our value to customers." Rick Cohen, Symbotic Chairman and Chief Executive Officer.
• "We also added Medline, our first customer in the health care vertical, and enter fiscal year 2026 enthusiastic about our prospects to broaden opportunities with customers." Rick Cohen, Symbotic Chairman and Chief Executive Officer.
• "Revenue exceeded our expectations, and we delivered strong gross margin expansion and free cash flow in the fiscal fourth quarter of 2025." Izzy Martins, Symbotic Chief Financial Officer.
• "Looking ahead, the start of fiscal year 2026 is unfolding consistent with the expectations we outlined last quarter as our customers continue their transition to our next generation storage structure." Izzy Martins, Symbotic Chief Financial Officer.

Industry Context

Symbotic operates in the rapidly evolving supply chain automation industry, addressing existential threats like labor pressures, SKU proliferation, and evolving omni-channel strategies. The company's AI-enabled robotics platform aims to transform distribution networks into strategic assets, positioning it as a leader in a large addressable market that includes in-house warehouse automation, outsourced warehouse-as-a-service (via GreenBox joint venture), and micro-fulfillment opportunities. The expansion into the healthcare vertical with Medline demonstrates diversification and adaptability to broader industry needs.

Comparison to Industry Standards

• Symbotic's AI-enabled, tech platform for supply chain transformation positions it against traditional point solutions and legacy automation alternatives, offering improved efficiency, speed, flexibility, density, and accuracy.
• The company's $22.5 billion contracted backlog with blue-chip customers like Walmart, C&S Wholesale Grocers, Albertsons, and Southern Glazer's Wine & Spirits, along with the GreenBox joint venture (35% ownership, ~$11B contract, unlocking $500B+ annual TAM), demonstrates strong market penetration and competitive advantage in the warehouse automation sector.
• The addition of Medline as its first healthcare vertical customer indicates successful expansion into new market segments, diversifying its customer base beyond retail and wholesale.
• The next-gen storage structure, announced in August 2025, aims for higher density, rapid assembly, enhanced safety, and integrated fire suppression, which could set new benchmarks for warehouse automation system design and implementation speed.

Related Party Transactions

• Symbotic and C&S Wholesale Grocers share common control through the Cohen family.

Stakeholder Impact

• Shareholders: Positive financial results, strong growth, and a substantial backlog could lead to increased shareholder value. However, continued GAAP net losses remain a point of concern.
• Customers: The introduction of the next-gen storage structure and expansion into new verticals like healthcare (Medline) suggests enhanced offerings and broader service capabilities, potentially improving customer efficiency and satisfaction.
• Employees: Continued growth, significant R&D investment, and patent activity may indicate job stability and opportunities for career development within the company.

Next Steps

• Continue customer transition to the next generation storage structure.
• Broaden opportunities with existing and new customers.
• Host a webcast on November 24, 2025, to discuss results.

Key Dates

Recommendation

Symbotic's strong fiscal year 2025 performance, marked by 26% revenue growth and a significant increase in adjusted EBITDA, demonstrates robust operational execution and market demand for its AI-enabled robotics technology. The substantial $22.5 billion contracted backlog provides excellent revenue visibility, and the expansion into the healthcare vertical with Medline signals successful market diversification. While the company still reports a GAAP net loss, the positive free cash flow generation and strong balance sheet with $1.245 billion in cash indicate financial health and capacity for continued investment. The positive outlook for Q1 FY26 further reinforces confidence in its growth trajectory, making it an attractive investment for long-term growth.

Keywords

Symbotic, SYM, Robotics, AI, Supply Chain Automation, Warehouse Automation, Financial Results, Earnings, EBITDA, Revenue Growth, Logistics Technology, Q4 2025, FY 2025, Medline, GreenBox, Nasdaq